Skip to main content
FinSpry Logo
FinSpry
MEDP logo
MEDP
(NASDAQ)
Medpace Holdings, Inc.
$455.66-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Medpace Holdings (MEDP) Stock Price & Financial Analysis

Medpace Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$447.95 - $463.34
52-Week High$628.92
52-Week Low$301.90
Open$463.05
Volume472.73K
Average Volume (3M)297.46K
Market Cap13.33B
Shares Outstanding28.96M
P/E Ratio (TTM)28.95
Forward P/E26.62
Price to Sales (P/S)4.98
Price to Book (P/B)22.28
EV/EBITDA21.55
Revenue (TTM)2.68B
Net Income (TTM)460.40M
Free Cash Flow (TTM)711.00M
EPS (TTM)$15.63
Profit Margin17.19%
Operating Margin21.02%
Return on Equity (ROE)76.95%
Debt to Equity0.20
50-Day MA$450.95
200-Day MA$512.46
52-Week Change52.04%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Medpace Holdings

What is the current stock price for MEDP?

As of the latest trading session, MEDP stock trades at $460.20. The 52-week range is $301.90–$628.92, with a day range of $447.95–$463.34.

What is the P/E ratio for MEDP?

Medpace Holdings's trailing P/E ratio is 28.9, meaning investors pay $28.9 for every $1 of annual earnings. The forward P/E is 26.6, reflecting analyst expectations for future earnings. Medpace Holdings operates in the Healthcare sector.

Does MEDP pay dividends?

Medpace Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MEDP?

Based on 10 analysts, the consensus for MEDP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MEDP?

Medpace Holdings's market capitalization is $13.33B, classifying it as a large-cap company. Medpace Holdings operates in the Healthcare sector within the Diagnostics & Research industry.